Suppr超能文献

底物和抑制剂对碳青霉烯酶-2 结构的影响。

Influence of substrates and inhibitors on the structure of carbapenemase-2.

机构信息

Department of Chemistry and Biochemistry, Miami University, Oxford, OH 45056, USA.

出版信息

Exp Biol Med (Maywood). 2019 Dec;244(17):1596-1604. doi: 10.1177/1535370219854322. Epub 2019 Jun 4.

Abstract

UNLABELLED

The hydrolysis of last resort carbapenem antibiotics by carbapenemase-2 (KPC-2) presents a significant danger to global health. Combined with horizontal gene transfer, the emergence KPC-2 threatens to quickly expand carbapenemase activity to ever increasing numbers of pathogens. Our understanding of KPC-2 has greatly increased over the past decade thanks, in great part, to 20 crystal structures solved by groups around the world. These include apo KPC-2 structures, along with structures featuring a library of 10 different inhibitors representing diverse structural and functional classes. Herein we focus on cataloging the available KPC-2 structures and presenting a discussion of key aspects of each structure and important relationships between structures. Although the available structures do not provide information on dynamic motions with KPC-2, and the family of structures indicates small conformational changes across a wide array of bound inhibitors, substrates, and products, the structures provide a strong foundation for additional studies in the coming years to discover new KPC-2 inhibitors.

IMPACT STATEMENT

The work herein is important to the field as it provides a clear and succinct accounting of available KPC-2 structures. The work advances the field by collecting and analyzing differences and similarities across the available structures. This work features new analyses and interpretations of the existing structures which will impact the field in a positive way by making structural insights more widely available among the beta-lactamase community.

摘要

未标记

由碳青霉烯酶-2(KPC-2)引起的最后手段碳青霉烯抗生素的水解对全球健康构成了重大威胁。与水平基因转移相结合,KPC-2 的出现威胁着迅速将碳青霉烯酶活性扩展到越来越多的病原体。由于全世界许多团体解决了 20 个晶体结构,我们对 KPC-2 的理解在过去十年中大大提高了。这些结构包括 apo KPC-2 结构,以及具有 10 种不同抑制剂的结构,这些抑制剂代表了不同的结构和功能类别。在这里,我们专注于对可用的 KPC-2 结构进行编目,并对每个结构的关键方面以及结构之间的重要关系进行讨论。尽管现有结构无法提供有关 KPC-2 动态运动的信息,并且该结构家族表明在广泛的结合抑制剂,底物和产物范围内存在小的构象变化,但这些结构为未来几年的进一步研究提供了坚实的基础,以发现新的 KPC-2 抑制剂。

影响说明

本文的工作对该领域很重要,因为它提供了可用的 KPC-2 结构的清晰简洁说明。该工作通过收集和分析可用结构之间的差异和相似性来推动该领域的发展。这项工作对现有结构进行了新的分析和解释,这将通过在β-内酰胺酶社区中更广泛地提供结构见解,对该领域产生积极影响。

相似文献

1
Influence of substrates and inhibitors on the structure of carbapenemase-2.
Exp Biol Med (Maywood). 2019 Dec;244(17):1596-1604. doi: 10.1177/1535370219854322. Epub 2019 Jun 4.
2
Identification of potential inhibitors for carbapenemase-3: a molecular docking and dynamics study.
J Biomol Struct Dyn. 2019 Oct;37(17):4601-4613. doi: 10.1080/07391102.2018.1556737. Epub 2019 Jan 11.
4
BLIP-II is a highly potent inhibitor of Klebsiella pneumoniae carbapenemase (KPC-2).
Antimicrob Agents Chemother. 2013 Jul;57(7):3398-401. doi: 10.1128/AAC.00215-13. Epub 2013 Apr 15.
5
In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.
Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1143-1150. doi: 10.1007/s10096-019-03517-y. Epub 2019 Mar 1.
7
First report of KPC-producing Klebsiella pneumoniae in Croatia.
J Chemother. 2012 Aug;24(4):237-9. doi: 10.1179/1973947812Y.0000000017.
8
Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae.
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.00174-18. Print 2018 Jun.

引用本文的文献

1
Structural Comparisons of Cefotaximase (CTX-M-ase) Sub Family 1.
Front Microbiol. 2021 Aug 24;12:688509. doi: 10.3389/fmicb.2021.688509. eCollection 2021.
3
Structural biology: Gaining atomic level insight into the biological function of macromolecules.
Exp Biol Med (Maywood). 2019 Dec;244(17):1507-1509. doi: 10.1177/1535370219887678. Epub 2019 Nov 13.

本文引用的文献

1
Conformational Intermediate That Controls KPC-2 Catalysis and Beta-Lactam Drug Resistance.
ACS Catal. 2018 Apr 6;8(4):2741-2747. doi: 10.1021/acscatal.7b03832. Epub 2018 Feb 21.
4
Beta-lactamase database (BLDB) - structure and function.
J Enzyme Inhib Med Chem. 2017 Dec;32(1):917-919. doi: 10.1080/14756366.2017.1344235.
5
Molecular Basis of Substrate Recognition and Product Release by the Klebsiella pneumoniae Carbapenemase (KPC-2).
J Med Chem. 2017 Apr 27;60(8):3525-3530. doi: 10.1021/acs.jmedchem.7b00158. Epub 2017 Apr 17.
6
Advances in free-energy-based simulations of protein folding and ligand binding.
Curr Opin Struct Biol. 2016 Feb;36:25-31. doi: 10.1016/j.sbi.2015.12.002. Epub 2016 Jan 7.
8
Crystal Structures of KPC-2 and SHV-1 β-Lactamases in Complex with the Boronic Acid Transition State Analog S02030.
Antimicrob Agents Chemother. 2016 Jan 4;60(3):1760-6. doi: 10.1128/AAC.02643-15.
9
Inhibition of Klebsiella β-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study.
PLoS One. 2015 Sep 4;10(9):e0136813. doi: 10.1371/journal.pone.0136813. eCollection 2015.
10
Ligand-Induced Proton Transfer and Low-Barrier Hydrogen Bond Revealed by X-ray Crystallography.
J Am Chem Soc. 2015 Jul 1;137(25):8086-95. doi: 10.1021/jacs.5b00749. Epub 2015 Jun 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验